Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Gepubliceerd in:
hoofdstuk lezen eerste hoofdstuk lezen

2024 | OriginalPaper | Hoofdstuk

24. History of near-infrared fluorescence

Auteurs : Drs. Daan J. Sikkenk, Prof. Dr. Esther C. J. Consten, Prof. Dr. Wouter B. Nagengast

Gepubliceerd in: The Technical Principles of Endoscopic Surgery

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Near infrared immunofluorescence (NIRF) is based on the excitation of fluorophores by light in a wavelength outside the visible spectrum. This excitation is visualized with a dedicated camera, which can display standard view, the excitation of the fluorophores on a grayscale background, or a combined image.
vorige hoofdstuk 2D and 3D endoscopic surgery
volgende hoofdstuk Electrical dissection techniques
Literatuur
1.
Young JK, Figueroa ER, Drezek RA. Tunable nanostructures as photothermal theranostic agents. Ann Biomed Eng. 2012;40(2):438–59.PubMedCrossRef
2.
Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin VV, et al. A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging. 2012;2012: 940585.PubMedPubMedCentralCrossRef
3.
4.
Food & Drug Administration. SPY SP2000 approval – K042961. 2005 [cited 2022 Apr 3]. Available from: k042961.
5.
Pogue BW, Rosenthal EL. Review of successful pathways for regulatory approvals in open-field fluorescence-guided surgery. J Biomed Opt. 2021;26(3).
6.
Stewart HL, Birch DJS. Fluorescence Guided Surgery. Methods Appl Fluoresc. 2021;9(4).
7.
Galema HA, Meijer RPJ, Lauwerends LJ, Verhoef C, Burggraaf J, Vahrmeijer AL, et al. Fluorescence-guided surgery in colorectal cancer; A review on clinical results and future perspectives. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2021. https://​pubmed.​ncbi.​nlm.​nih.​gov/​34657780/​
8.
Landsman ML, Kwant G, Mook GA, Zijlstra WG. Light-absorbing properties, stability, and spectral stabilization of indocyanine green. J Appl Physiol. 1976;40(4):575–83.PubMedCrossRef
9.
Maarek J-MI, Holschneider DP. Estimation of indocyanine green concentration in blood from fluorescence emission: application to hemodynamic assessment during hemodialysis. J Biomed Opt. 2009;14(5):54006.
10.
Speich R. Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med. 1988;109(4):345.PubMedCrossRef
11.
12.
Mindt S, Karampinis I, John M, Neumaier M, Nowak K. Stability and degradation of indocyanine green in plasma, aqueous solution and whole blood. Photochem Photobiol Sci Off J Eur Photochem Assoc Eur Soc Photobiol. 2018;17(9):1189–96.
13.
Mordon S, Devoisselle JM, Soulie-Begu S, Desmettre T. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc Res. 1998;55(2):146–52.PubMedCrossRef
14.
Kraft JC, Ho RJY. Interactions of indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo. Biochemistry. 2014;53(8):1275–83.CrossRef
15.
Schouw HM, Huisman LA, Janssen YF, Slart RHJA, Borra RJH, Willemsen ATM, et al. Targeted optical fluorescence imaging: a meta-narrative review and future perspectives. Eur J Nucl Med Mol Imaging. 2021;48(13):4272–92.PubMedPubMedCentralCrossRef
16.
Lwin TM, Turner MA, Amirfakhri S, Nishino H, Hoffman RM, Bouvet M. Fluorescence molecular targeting of colon cancer to visualize the invisible. Cells. 2022;11(2).
17.
Van Oosten M, Crane LM, Bart J, Van Leeuwen FW, Van Dam GM. Selecting potential targetable biomarkers for imaging purposes in colorectal cancer using target selection criteria (TASC): a novel target identification tool. Transl Oncol. 2011;4(2):71–82.PubMedPubMedCentralCrossRef
18.
Lamberts L, Koch M, De Jong J, Adams A, Glatz J, Kranendonk M, et al. Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study. Clin Cancer Res. 2017;23(11):2730–41.PubMedCrossRef
19.
Nagengast WB, Hartmans E, Garcia-Allende PB, Peters FTM, Linssen MD, Koch M, et al. Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A. Gut. 2019;68(1):7–10.PubMedCrossRef
20.
De Jongh SJ, Tjalma JJJ, Koller M, Linssen MD, Vonk J, Dobosz M, et al. Back-table fluorescence-guided imaging for circumferential resection margin evaluation using bevacizumab-800CW in patients with locally advanced rectal cancer. J Nucl Med. 2020;61(5):655–61.PubMedPubMedCentralCrossRef
21.
Hartmans E, Tjalma JJJ, Linssen MD, Allende PBG, Koller M, Jorritsma-Smit A, et al. Potential red-flag identification of colorectal adenomas with wide-field fluorescence molecular endoscopy. Theranostics. 2018;8(6):1458–67.PubMedPubMedCentralCrossRef
22.
Tjalma JJJ, Koller M, Linssen MD, Hartmans E, De Jongh SJ, Jorritsma-Smit A, et al. Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer. Gut. 2020;69(3):406–10.PubMedCrossRef
23.
Harlaar NJ, Koller M, De Jongh SJ, Van Leeuwen BL, Hemmer PH, Kruijff S, et al. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol Hepatol. 2016;1(4):283–90.PubMedCrossRef
24.
Steinkamp PJ, Pranger BK, Li M-F, Linssen MD, Voskuil FJ, Been LB, et al. Fluorescence-guided visualization of soft-tissue sarcomas by targeting vascular endothelial growth factor A: a phase 1 single-center clinical trial. J Nucl Med. 2021;62(3):342–7.PubMedCrossRef
25.
Vonk J, Voskuil FJ, De Wit JG, Heeman WT, Nagengast WB, Van Dam GM, et al. Fluorescence grid analysis for the evaluation of piecemeal surgery in sinonasal inverted papilloma: a proof-of-concept study. Eur J Nucl Med Mol Imag. 2022;49(5):1640–9.CrossRef
26.
Vergeer RA, Postma MR, Schmidt I, Korsten-Meijer AG, Feijen RA, Kruijff S, et al. Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-findin. BMJ Open. 2021;11(10): e049109.PubMedPubMedCentralCrossRef
27.
Gutowski M, Framery B, Boonstra MC, Garambois V, Quenet F, Dumas K, et al. SGM-101: an innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery. Surg Oncol. 2017;26(2):153–62.PubMedCrossRef
28.
Tiernan JP, Perry SL, Verghese ET, West NP, Yeluri S, Jayne DG, et al. Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. Br J Cancer. 2013;108(3):662–7.PubMedPubMedCentralCrossRef
29.
Boucher D, Cournoyer D, Stanners CP, Fuks A. Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res. 1989;49(4):847–52.PubMed
30.
Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, Van der Valk MJM, et al. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Lancet Gastroenterol Hepatol. 2018;3(3):181–91.
31.
Meijer RPJ, De Valk KS, Deken MM, Boogerd LSF, Hoogstins CES, Bhairosingh SS, et al. Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2021;47(3 Pt B):667–73.
32.
Vuijk FA, Hilling DE, Mieog JSD, Vahrmeijer AL. Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer. J Surg Oncol. 2018;118:315–23.
33.
Schaap DP, De Valk KS, Deken MM, Meijer RPJ, Burggraaf J, Vahrmeijer AL, et al. Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Br J Surg. 2020;107(4):334–7.PubMedCrossRef
34.
35.
Pucher PH, Brunt LM, Davies N, Linsk A, Munshi A, Rodriguez HA, et al. Outcome trends and safety measures after 30 years of laparoscopic cholecystectomy: a systematic review and pooled data analysis. Surg Endosc. 2018;32(5):2175–83.PubMedPubMedCentralCrossRef
36.
Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, et al. 2016 WSES guidelines on acute calculous cholecystitis. World J Emerg Surg. 2016;11:25.PubMedPubMedCentralCrossRef
37.
Strasberg SM, Hertl M, Soper NJ. An analysis of the problem of biliary injury during laparoscopic cholecystectomy. J Am Coll Surg. 1995;180(1):101–25.PubMed
38.
Dip FD, Asbun D, Rosales-Velderrain A, Lo Menzo E, Simpfendorfer CH, Szomstein S, et al. Cost analysis and effectiveness comparing the routine use of intraoperative fluorescent cholangiography with fluoroscopic cholangiogram in patients undergoing laparoscopic cholecystectomy. Surg Endosc. 2014;28(6):1838–43.PubMedCrossRef
39.
Flum DR, Dellinger EP, Cheadle A, Chan L, Koepsell T. Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy. JAMA. 2003;289(13):1639–44.PubMedCrossRef
40.
Rystedt JML, Tingstedt B, Montgomery F, Montgomery AK. Routine intraoperative cholangiography during cholecystectomy is a cost-effective approach when analysing the cost of iatrogenic bile duct injuries. HPB (Oxford). 2017;19(10):881–8.PubMedCrossRef
41.
Törnqvist B, Strömberg C, Akre O, Enochsson L, Nilsson M. Selective intraoperative cholangiography and risk of bile duct injury during cholecystectomy. Br J Surg. 2015;102(8):952–8.PubMedCrossRef
42.
Lim SH, Tan HTA, Shelat VG. Comparison of indocyanine green dye fluorescent cholangiography with intra-operative cholangiography in laparoscopic cholecystectomy: a meta-analysis. Surg Endosc. 2021;35(4):1511–20.PubMedCrossRef
43.
Strasberg SM, Brunt LM. Rationale and use of the critical view of safety in laparoscopic cholecystectomy. J Am Coll Surg. 2010;211(1):132–8.PubMedCrossRef
44.
Lehrskov LL, Westen M, Larsen SS, Jensen AB, Kristensen BB, Bisgaard T. Fluorescence or X-ray cholangiography in elective laparoscopic cholecystectomy: a randomized clinical trial. Br J Surg. 2020;107(6):655–61.PubMedCrossRef
45.
Pesce A, Piccolo G, La Greca G, Puleo S. Utility of fluorescent cholangiography during laparoscopic cholecystectomy: a systematic review. World J Gastroenterol. 2015;21(25):7877–83.PubMedPubMedCentralCrossRef
46.
Dip F, LoMenzo E, Sarotto L, Phillips E, Todeschini H, Nahmod M, et al. Randomized trial of near-infrared incisionless fluorescent cholangiography. Ann Surg. 2019;270(6):992–9.PubMedCrossRef
47.
Dip F, Aleman R, Frieder JS, Gomez CO, Menzo E Lo, Szomstein S, et al. Understanding intraoperative fluorescent cholangiography: ten steps for an effective and successful procedure. Surg Endosc. 2021;35(12):7042–8.
48.
49.
50.
Chen Q, Zhou R, Weng J, Lai Y, Liu H, Kuang J, et al. Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time. Surg Endosc. 2021;35(10):5573–82.PubMedCrossRef
51.
Boogerd LSF, Handgraaf HJM, Huurman VAL, Lam H-D, Mieog JSD, Van der Made WJ, et al. The best approach for laparoscopic fluorescence cholangiography: overview of the literature and optimization of dose and dosing time. Surg Innov. 2017;24(4):386–96.PubMedPubMedCentralCrossRef
52.
Cárdenas G, Fornaguera I, Díaz Del Gobbo R, Ginestà C. Direct gallbladder indocyanine green injection technique to achieve critical view of safety in laparoscopic cholecystectomy. Cir Esp. 2021;99(9):678–82.PubMedCrossRef
53.
Liu Y-Y, Kong S-H, Diana M, Lègner A, Wu C-C, Kameyama N, et al. Near-infrared cholecysto-cholangiography with indocyanine green may secure cholecystectomy in difficult clinical situations: proof of the concept in a porcine model. Surg Endosc. 2016;30(9):4115–23.PubMedCrossRef
54.
Graves C, Ely S, Idowu O, Newton C, Kim S. Direct gallbladder indocyanine green injection fluorescence cholangiography during laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A. 2017;27(10):1069–73.PubMedCrossRef
55.
Warps AK, Dekker JWT, Tanis PJ, Tollenaar RAEM. An evaluation of short-term outcomes after reoperations for anastomotic leakage in colon cancer patients. Int J Colorectal Dis. 2022;37(1):113–22.PubMedCrossRef
56.
De Nardi P, Elmore U, Maggi G, Maggiore R, Boni L, Cassinotti E, et al. Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial. Surg Endosc. 2020;34(1):53–60.PubMedCrossRef
57.
Alekseev M, Rybakov E, Shelygin Y, Chernyshov S, Zarodnyuk I. A study investigating the perfusion of colorectal anastomoses using fluorescence angiography: results of the FLAG randomized trial. Color Dis Off J Assoc Coloproctology Gt Britain Irel. 2020;22(9):1147–53.
58.
Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010;147(3):339–51.PubMedCrossRef
59.
Jafari MD, Pigazzi A, McLemore EC, Mutch MG, Haas E, Rasheid SH, et al. Perfusion assessment in left-sided/low anterior resection (PILLAR III): a randomized, controlled, parallel, multicenter study assessing perfusion outcomes with PINPOINT near-infrared fluorescence imaging in low anterior resection. Dis Colon Rectum. 2021;64(8):995–1002.PubMedCrossRef
60.
Emile SH, Khan SM, Wexner SD. Impact of change in the surgical plan based on indocyanine green fluorescence angiography on the rates of colorectal anastomotic leak: a systematic review and meta-analysis. Surg Endosc. 2022;36(4):2245–57.PubMedCrossRef
61.
Armstrong G, Croft J, Corrigan N, Brown JM, Goh V, Quirke P, et al. IntAct: intra-operative fluorescence angiography to prevent anastomotic leak in rectal cancer surgery: a randomized controlled trial. Color Dis Off J Assoc Coloproctology Gt Britain Irel. 2018;20(8):O226–34.
62.
Meijer RPJ, Faber RA, Bijlstra OD, Braak JPBM, Meershoek-Klein Kranenbarg E, Putter H, et al. AVOID; a phase III, randomised controlled trial using indocyanine green for the prevention of anastomotic leakage in colorectal surgery. BMJ Open. 2022;12(4): e051144.PubMedPubMedCentralCrossRef
63.
Slooter MD, Talboom K, Sharabiany S, Van Helsdingen CPM, Van Dieren S, Ponsioen CY, et al. IMARI: multi-Interventional program for prevention and early Management of Anastomotic leakage after low anterior resection in Rectal cancer patIents: rationale and study protocol. BMC Surg. 2020;20(1):240.PubMedPubMedCentralCrossRef
64.
Ekman M, Girnyi S, Marano L, Roviello F, Chand M, Diana M, et al. Near-infrared fluorescence image-guided surgery in esophageal and gastric cancer operations. Surg Innov. 2022;15533506211073416.
65.
Slooter MD, Eshuis WJ, Cuesta MA, Gisbertz SS, Van Berge Henegouwen MI. Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: a systematic review and meta-analysis. J Thorac Dis. 2019;11(Suppl 5):S755–65.PubMedPubMedCentralCrossRef
66.
Casas MA, Angeramo CA, Bras Harriott C, Dreifuss NH, Schlottmann F. Indocyanine green (ICG) fluorescence imaging for prevention of anastomotic leak in totally minimally invasive Ivor Lewis esophagectomy: a systematic review and meta-analysis. Dis esophagus Off J Int Soc Dis Esophagus. 2022;35(4).
67.
Hardy NP, Dalli J, Khan MF, Andrejevic P, Neary PM, Cahill RA. Inter-user variation in the interpretation of near infrared perfusion imaging using indocyanine green in colorectal surgery. Surg Endosc. 2021;35(12):7074–81.PubMedCrossRef
68.
Gomez-Rosado J-C, Valdes-Hernandez J, Cintas-Catena J, Cano-Matias A, Perez-Sanchez A, Del Rio-Lafuente F-J, et al. Feasibility of quantitative analysis of colonic perfusion using indocyanine green to prevent anastomotic leak in colorectal surgery. Surg Endosc. 2022;36(2):1688–95.PubMedCrossRef
69.
Goncalves LN, Van den Hoven P, Van Schaik J, Leeuwenburgh L, Hendricks CHF, Verduijn PS, et al. Perfusion parameters in near-infrared fluorescence imaging with indocyanine green: a systematic review of the literature. Life (Basel, Switzerland). 2021;11(5).
70.
Keereweer S, Van Driel PBAA, Snoeks TJA, Kerrebijn JDF, Baatenburg de Jong RJ, Vahrmeijer AL, et al. Optical image-guided cancer surgery: challenges and limitations. Clin cancer Res an Off J Am Assoc Cancer Res. 2013;19(14):3745–54.
71.
Lauwerends LJ, Van Driel PBAA, Baatenburg de Jong RJ, Hardillo JAU, Koljenovic S, Puppels G, et al. Real-time fluorescence imaging in intraoperative decision making for cancer surgery. Lancet Oncol. 2021;22(5):e186–95.
72.
Lütken CD, Achiam MP, Svendsen MB, Boni L, Nerup N. Optimizing quantitative fluorescence angiography for visceral perfusion assessment. Surg Endosc. 2020;34(12):5223–33.PubMedCrossRef
73.
Van den Hoven P, Van den Berg SD, Van der Valk JP, Van der Krogt H, Van Doorn LP, Van de Bogt KEA, et al. Assessment of tissue viability following amputation surgery using near-infrared fluorescence imaging with indocyanine green. Ann Vasc Surg. 2022;78:281–7.PubMedCrossRef
74.
75.
Liu H-J, Sun M-S, Liu L-Y, Yu Z-H, Chen X-X, Liu Q, et al. The detection rate of methylene blue combined with another tracer in sentinel lymph node biopsy of early-stage breast cancer: a systematic review and network meta-analysis. Transl Cancer Res. 2021;10(12):5222–37.PubMedPubMedCentralCrossRef
76.
Lafreniere A-S, Shine JJ, Nicholas CR, Temple-Oberle CF. The use of indocyanine green and near-infrared fluorescence imaging to assist sentinel lymph node biopsy in cutaneous melanoma: a systematic review. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2021;47(5):935–41.
77.
Sánchez-Guillén L, Frasson M, García-Granero, Pellino G, Flor-Lorente B, Álvarez-Sarrado E, et al. Risk factors for leak, complications and mortality after ileocolic anastomosis: Comparison of two anastomotic techniques. Ann R Coll Surg Engl. 2019;101(8):571–8.
78.
Dohrn N, Klein MF, Gögenur I. Robotic versus laparoscopic right colectomy for colon cancer: a nationwide cohort study. Int J Colorectal Dis. 2021;36(10):2147–58.PubMedCrossRef
79.
Van den Bosch T, Warps A-LK, De Nerée Tot Babberich MPM, Stamm C, Geerts BF, Vermeulen L, et al. Predictors of 30-day mortality among dutch patients undergoing colorectal cancer surgery, 2011–2016. JAMA Netw Open. 2021 Apr 1;4(4):e217737–7.
80.
De Neree Tot Babberich MPM, Vermeer NCA, Wouters MWJM, Van Grevenstein WMU, Peeters KCMJ, Dekker E, et al. Postoperative outcomes of screen-detected vs non-screen-detected colorectal cancer in the Netherlands. JAMA Surg. 2018;153(12):e183567.
81.
Currie AC. Intraoperative sentinel node mapping in the colon: potential and pitfalls. Eur Surg Res. 2019;60:45–52.PubMedCrossRef
82.
Van der Pas MHGM, Meijer S, Hoekstra OS, Riphagen II, De Vet HC, Knol DL, et al. Sentinel-lymph-node procedrue in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol. 2011;12:540–50.PubMedCrossRef
83.
Des Guetz G, Uzzan B, Nicolas P, Cucherat M, De Mestier P, Morere JF, et al. Is sentinel lymph node mapping in colorectal cancer a future prognostic factor? A meta-analysis. World J Surg. 2007;31(6):1304–12.PubMedCrossRef
84.
Joosten J, Strobbe L, Wauters C, Pruszczynski M, Wobbes T, Ruers T. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg. 1999;86(4):482–6.PubMedCrossRef
85.
Patten L, Berger D, Rodriguez-Bigas M, Mansfield P, Delpassand E, Cleary K, et al. A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer. 2004;100(10):2104–9.PubMedCrossRef
86.
Doekhie F, Kuppen P, Peeters K, Mesker W, Van Soest R, Morreau H, et al. Doekhie FS, Kuppen PJK, Peeters KCMJ, Mesker WE, Van Soest RA, Morreau H, et al. Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer. Eur J Surg Oncol. 2006;32(3):253–8.
87.
Grinnell R. Lymphatic block with atypical and retrograde lymphatic metastasis and spread in carcinoma of the colon and rectum. Ann Surg. 1966;163(2):272–80.PubMedPubMedCentralCrossRef
88.
Kusano M, Tajima Y, Yamazaki K, Kato M, Watanabe M, Miwa M. Sentinel node mapping guided by indocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastrointestinal cancer. Dig Surg. 2008;25(2):103–8.PubMedCrossRef
89.
Nagata K, Endo S, Hidaka E, Tanaka JI, Kudo SE, Shiokawa A. Laparoscopic sentinel node mapping for colorectal cancer using infrared ray laparoscopy. Anticancer Res. 2006;26(3 B):2307–11.
90.
Cahill RA, Anderson M, Wang LM, Lindsey I, Cunningham C, Mortensen NJ. Near-infrared (NIR) laparoscopy for intraoperative lymphatic road-mapping and sentinel node identification during definitive surgical resection of early-stage colorectal neoplasia. Surg Endosc. 2012;26(1):197–204.PubMedCrossRef
91.
Hirche C, Mohr Z, Kneif S, Doniga S, Murawa D, Strik M, et al. Ultrastaging of colon cancer by sentinel node biopsy using fluorescence navigation with indocyanine green. Int J Colorectal Dis. 2012;27(3):319–24.PubMedCrossRef
92.
Ankersmit M, Hoekstra OS, Van Lingen A, Bloemena E, Jacobs MAJM, Vugts DJ, et al. Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer. Eur J Nucl Med Mol Imag. 2019; https://​pubmed.​ncbi.​nlm.​nih.​gov/​30798428/​
93.
Van Der PMHGM, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WCJ, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14:210–8.CrossRef
94.
Currie AC, Brigic A, Thomas-Gibson S, Suzuki N, Moorghen M, Jenkins JT, et al. A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer. Eur J Surg Oncol. 2017;43(11):2044–51.PubMedCrossRef
95.
Chand M, Keller DS, Joshi HM, Devoto L, Rodriguez-Justo M, Cohen R. Feasibility of fluorescence lymph node imaging in colon cancer: FLICC. Tech Coloproctol. 2018;22(4):271–7.PubMedCrossRef
96.
Andersen HS, Bennedsen ALB, Burgdorf SK, Eriksen JR, Eiholm S, Toxværd A, et al. In vivo and ex vivo sentinel node mapping does not identify the same lymph nodes in colon cancer. Int J Colorectal Dis. 2017;32(7):983–90.PubMedCrossRef
97.
Dan AG, Saha S, Monson KM, Wiese D, Schochet E, Barber KR, et al. 1 % lymphazurin vs 10 % fluorescein for sentinel node mapping in colorectal tumors. Archiv. 2014;139:1180–4.
98.
Burghgraef TA, Zweep AL, Sikkenk DJ, Van der Pas MHGM, Verheijen PM, Consten ECJ. In vivo sentinel lymph node identification using fluorescent tracer imaging in colon cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;2021(158): 103149.
99.
Leicher LW, De Vos Tot Nederveen Cappel WH, Van Westreenen HL. Limited endoscopic-assisted wedge resection for excision of colon polyps. Dis Colon Rectum. 2017;60(3):299–302.
100.
101.
Huang Y, Pan M, Chen B. A systematic review and meta-analysis of sentinel lymph node biopsy in gastric cancer, an optimization of imaging protocol for tracer mapping. World J Surg. 2021;45(4):1126–34.PubMedCrossRef
102.
Huang L, Wei T, Chen J, Zhou D. Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies. World J Surg Oncol. 2017;15(1):103.PubMedPubMedCentralCrossRef
103.
Zhong Q, Chen Q-Y, Huang X-B, Lin G-T, Liu Z-Y, Chen J-Y, et al. Clinical implications of Indocyanine Green Fluorescence Imaging-Guided laparoscopic lymphadenectomy for patients with gastric cancer: a cohort study from two randomized, controlled trials using individual patient data. Int J Surg. 2021;94: 106120.PubMedCrossRef
104.
Eom BW, Kim CG, Kook M-C, Yoon HM, Ryu KW, Kim Y-W, et al. Non-exposure simple suturing endoscopic full-thickness resection with sentinel basin dissection in patients with early gastric cancer: the SENORITA 3 pilot study. J Gastric Cancer. 2020;20(3):245–55.PubMedPubMedCentralCrossRef
105.
Jimenez-Lillo J, Villegas-Tovar E, Momblan-Garcia D, Turrado-Rodriguez V, Ibarzabal-Olano A, De Lacy B, et al. Performance of indocyanine-green imaging for sentinel lymph node mapping and lymph node metastasis in esophageal cancer: systematic review and meta-analysis. Ann Surg Oncol. 2021;28(9):4869–77.PubMedCrossRef
106.
Overwater A, Weusten BLAM, Ruurda JP, Van Hillegersberg R, Bennink RJ, De Keizer B, et al. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green. Surg Endosc. 2022;36(4):2671–9.PubMedCrossRef
107.
Kinami S, Oonishi T, Fujita J, Tomita Y, Funaki H, Fujita H, et al. Optimal settings and accuracy of indocyanine green fluorescence imaging for sentinel node biopsy in early gastric cancer. Oncol Lett. 2016;11(6):4055–62.PubMedPubMedCentralCrossRef
108.
Yaguchi Y, Ichikura T, Ono S, Tsujimoto H, Sugasawa H, Sakamoto N, et al. How should tracers be injected to detect for sentinel nodes in gastric cancer – submucosally from inside or subserosally from outside of the stomach? J Exp Clin Cancer Res. 2008;27(1):79.PubMedPubMedCentralCrossRef
109.
Unthank JL, Bohlen HG. Lymphatic pathways and role of valves in lymph propulsion from small intestine. Am J Physiol. 1988;254(3 Pt 1):G389–98.PubMed
110.
Manca G, Garau LM, Mazzarri S, Mazzuca L, Muccioli S, Ghilli M, et al. Novel experience in hybrid tracers: clinical evaluation of feasibility and efficacy in using ICG-99mTc nanotop for sentinel node procedure in breast cancer patients. Clin Nucl Med. 2021;46(4):e181–7.PubMedCrossRef
111.
Rietbergen DDD, Meershoek P, KleinJan GH, Donswijk M, Valdés Olmos RA, Van Leeuwen FWB, et al. Head-to-head comparison of the hybrid tracer indocyanine green-99mTc-nanocolloid with 99mTc-Senti-Scint using sentinel node lymphoscintigraphy and single-photon emission computed tomography combined with computer tomography in melanoma. Nucl Med Commun. 2020;41(10):1010–7.PubMedCrossRef
112.
Krishnan G, Van den Berg NS, Nishio N, Juniper G, Pei J, Zhou Q, et al. Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW. Theranostics. 2021;11(15):7188–98.PubMedPubMedCentralCrossRef
113.
Marcelissen TAT, Den Hollander PP, Tuytten TRAH, Sosef MN. Incidence of iatrogenic ureteral injury during open and laparoscopic colorectal surgery: a single center experience and review of the literature. Surg Laparosc Endosc Percutan Tech. 2016;26(6):513–5.PubMedCrossRef
114.
Palaniappa NC, Telem DA, Ranasinghe NE, Divino CM. Incidence of iatrogenic ureteral injury after laparoscopic colectomy. Arch Surg. 2012;147(3):267–71.PubMedCrossRef
115.
Mahendran HA, Praveen S, Ho C, Goh EH, Tan GH, Zuklifli MZ. Iatrogenic ureter injuries: eleven years experience in a tertiary hospital. Med J Malaysia. 2012;67(2):169–72.PubMed
116.
117.
Slooter MD, Janssen A, Bemelman WA, Tanis PJ, Hompes R. Currently available and experimental dyes for intraoperative near-infrared fluorescence imaging of the ureters: a systematic review. Tech Coloproctol. 2019;23(4):305–13.PubMedPubMedCentralCrossRef
118.
Van Beurden F, Van Willigen DM, Vojnovic B, Van Oosterom MN, Brouwer OR, Van der Poel HG, et al. Multi-wavelength fluorescence in image-guided surgery, clinical feasibility and future perspectives. Mol Imag. 2020;19:1536012120962333.
119.
Hu Z, Fang C, Li B, Zhang Z, Cao C, Cai M, et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nat Biomed Eng. 2020;4(3):259–71.PubMedCrossRef
120.
121.
Broeders IAMJ, Kalisingh SS. Handboek endoscopische chirurgie. Houten: Bohn Stafleu van Loghum; 2009.
Metagegevens
Titel
History of near-infrared fluorescence
Auteurs
Drs. Daan J. Sikkenk
Prof. Dr. Esther C. J. Consten
Prof. Dr. Wouter B. Nagengast
Copyright
2024
Uitgeverij
Bohn Stafleu van Loghum
Boek
The Technical Principles of Endoscopic Surgery

Print ISBN: 978-90-368-2904-5

Elektronisch ISBN: 978-90-368-2905-2

Copyright: 2024

DOI
https://doi.org/10.1007/978-90-368-2905-2_24